Rendering

Component: (Network and Table)
Network
049 - Disclosure - Note 10 - Accrued Expenses - Accrued Expenses (Details)
(http://www.anikatherapeutics.com/20161231/role/statement-note-10-accrued-expenses-accrued-expenses-details)
TableStatement [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000898437 (http://www.sec.gov/CIK)
Scenario [Axis]Scenario, Unspecified [Domain]
Statement [Line Items]Period [Axis]
2016-12-31
2015-12-31
Compensation and related expenses
3,089,000  
3,082,000  
Facility construction costs
804,000  
415,000  
Research grants
463,000  
381,000  
Clinical trial costs
227,000  
252,000  
Professional fees
802,000  
210,000  
Deferred Rent
231,000  
xsi:nil  
Other
880,000  
438,000  
Total
6,496,000  
 
4,778,000